Daily Archives: September 28, 2020
Meta-analysis: Susceptibility to SARS-CoV-2 infection among children and adolescents compared with adults
28 Sep, 2020 | 01:39h | UTCEditorial: It’s Time to Put Children and Young People First During the Global COVID-19 Pandemic
Commentaries on Twitter
Susceptibility to #COVID19 for children and adolescents is about half of that of adults. A review of 32 studies w/ >41,000 chidden and adolescents. @JAMAPediatrics todayhttps://t.co/p1B37igez6 pic.twitter.com/F2q6LdQu1N
— Eric Topol (@EricTopol) September 25, 2020
Great editorial @JAMAPediatrics by @apsmunro & @SaulFaust, emphasizing that long-term effects and children's well-being SHOULD also matter, not just their role in the transmission chain. You'd think we'd have heard this sooner. I certainly did not.https://t.co/MMqrwkHgn5
— Ioana A. Cristea (@IoanaA_Cristea) September 26, 2020
IDSA updated guidelines on the treatment of patients with COVID-19
28 Sep, 2020 | 01:40h | UTC
Commentary on Twitter
.@IDSAInfo has updated its #COVID19 treatment guidelines:
*Don't give #tocilizumab
*Give #dexamethasone but not if room air oxygen saturation is > 94%https://t.co/66nwQQZgsz pic.twitter.com/PQNAaFBZS4— Mike Stevens (@Dr_Mike_Stevens) September 26, 2020
Coronavirus update with Anthony S. Fauci, MD
28 Sep, 2020 | 01:37h | UTCCoronavirus Update With Anthony S. Fauci, MD – September 25, 2020 – JAMA
Characteristics of health care personnel with COVID-19 in the US
28 Sep, 2020 | 01:34h | UTC
Commentary on Twitter
New @CDCMMWR shows 100,570 #COVID19 cases, with 641 deaths, among healthcare personnel from Feb 12-July 16. In 6 states, most worked in nursing & residential care facilities, and nurses were the most commonly reported job type.https://t.co/86DC1uz4ye pic.twitter.com/7JogA8MjXt
— CDC (@CDCgov) September 24, 2020
Changing age distribution of the COVID-19 pandemic in the US
28 Sep, 2020 | 01:36h | UTCCommentaries: Younger Americans Are Eclipsing Older Age Groups in COVID-19 Case Counts – TIME AND By August, 1 in 5 Covid-19 cases was someone in their 20s – CNN
Commentary on Twitter
Study showing that an increase in #COVID19 cases in young adults in the US preceded an increase in cases in those aged 60 years and older by an average of 9 days.
Infections in young people are important. The virus does not stay in this age group.https://t.co/TWIGS1Rg8A pic.twitter.com/tgr4xMzTe2
— Dr Zoë Hyde (@DrZoeHyde) September 26, 2020
ECMO in Covid-19: An international cohort
28 Sep, 2020 | 01:33h | UTC
Runny nose, stay home? Canada schools debate how to act on common cold symptoms
28 Sep, 2020 | 01:32h | UTCRunny nose, stay home? Canada schools debate how to act on common cold symptoms – Reuters
Tuberculosis and Covid-19: Fighting a deadly syndemic
28 Sep, 2020 | 01:31h | UTCTuberculosis And Covid-19: Fighting A Deadly Syndemic – Forbes
COVID-vaccine results are on the way — and scientists’ concerns are growing
28 Sep, 2020 | 01:33h | UTCCOVID-vaccine results are on the way — and scientists’ concerns are growing – Nature
Commentary on Twitter
Several ongoing coronavirus-vaccine trials could announce game-changing results next month. Scientists, though, have growing concerns. Here are the three areas they are watching closely. https://t.co/QxyA1zM0rY
— Nature (@nature) September 26, 2020
[Abstract Only] Randomized trial tests metformin in women with type 2 diabetes in pregnancy
28 Sep, 2020 | 01:30h | UTCCommentary: Welcome news for pregnant women with type 2 diabetes – MedicalXpress
Commentary on Twitter
Important findings from RCT of Metformin in 502 women with type 2 diabetes in pregnancy (MiTy): Improves maternal glucose✅, reduces maternal weight gain ✅, reduces insulin dosage ✅, leads to fewer large infants ✅ but more SGA ….? https://t.co/YVHj56nhuN
— Prof Eleanor Scott (@TIME_research) September 18, 2020
Randomized trial: Prophylactic negative pressure wound therapy does not benefit obese women after cesarean delivery
28 Sep, 2020 | 01:29h | UTCEffect of Prophylactic Negative Pressure Wound Therapy vs Standard Wound Dressing on Surgical-Site Infection in Obese Women After Cesarean Delivery: A Randomized Clinical Trial – JAMA (free for a limited period)
Commentary on Twitter
In this RCT, prophylactic negative pressure wound therapy did not reduce risk of surgical-site infection vs standard #woundcare in women with #obesity after cesarean delivery https://t.co/9Pz2YIAZKE
— JAMA (@JAMA_current) September 24, 2020
Review: Managing minimally abnormal cervical cancer screening test results
28 Sep, 2020 | 01:27h | UTCManaging Minimally Abnormal Cervical Cancer Screening Test Results – JAMA (free for a limited period)
Commentary on Twitter
The most common #cervicalcancer screening test abnormality is a #HPV result with normal cytology, which can be followed up with repeat testing at 1 year. But if HPV-16 is positive, immediate CIN3 risk rises to 5.3%, warranting colposcopy https://t.co/pipEzN3zrA @UCSFHospitals
— JAMA (@JAMA_current) September 25, 2020
Personal experiences or anecdotes (stories) are an unreliable basis for assessing the effects of most treatments
28 Sep, 2020 | 01:24h | UTC
Commentary on Twitter
‘It ain’t so much the things we don’t know that get us into trouble. It’s the things we know that just ain’t so.’ – Anon. https://t.co/8vyoayvyZ7 In this @CochraneUK blog, @elainefin4 of @iHealthFacts1 explains why personal experiences, or anecdotes, are unreliable evidence. pic.twitter.com/PqHrnGPvSM
— Students4BE (@Students4BE) September 27, 2020
Randomized trial: Gabapentin not effective for chronic pelvic pain in women
28 Sep, 2020 | 01:25h | UTCCommentary: Common pelvic pain drug is ineffective, study finds – University of Edinburgh
Commentary on Twitter
1/5 Pleased to announce publication of our @GaPP2_trial in @lancet today – the largest ever study into treatment for female chronic pelvic pain @exppect @MRC_CRH @EdinUniMedicine @EdinUniMedia @NIHRresearch @BhamCTU @GynaeResearcher https://t.co/NYEAxo2VAh https://t.co/A0ZOr8gqc3 pic.twitter.com/zwn8F7KRHO
— Andrew Horne (@horne_research) September 25, 2020
[Abstract Only] Meta-analysis: Direct oral anticoagulants for cancer-associated venous thromboembolism
28 Sep, 2020 | 01:22h | UTC
Harvard University says it can’t afford journal publishers’ prices
28 Sep, 2020 | 01:23h | UTCHarvard University says it can’t afford journal publishers’ prices – The Guardian
Related: UC Terminates Subscriptions with World’s Largest Scientific Publisher in Push for Open Access (several resources on the subject)